Mocertatug rezetecan, CAS [[3042848-25-6]]

Produktübersicht

• Artikelname: Mocertatug rezetecan, CAS [[3042848-25-6]]
• Artikelnummer: MCE-HY-185280
• Hersteller Artikelnummer: HY-185280
• Alternativnummer: MCE-HY-185280-10MG,MCE-HY-185280-5MG,MCE-HY-185280-1MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: HS-20089, GSK5733584

Produktbeschreibung

Mocertatug rezetecan (HS-20089, GSK5733584) is an antibody-drug conjugate (ADC) targeting B7-H4. Mocertatug rezetecan exhibits activity against platinum-resistant ovarian cancer. Mocertatug rezetecan is used for the research of advanced solid tumors, especially ovarian cancer and triple-negative breast cancer[1][2].

Produkteigenschaften

• Reinheit: 97.29
• CAS Nummer: [3042848-25-6]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs)

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: ADC Related